Promising Techniques for Extending the Life of an Organ Transplant ...

The work using protein therapeutics aims to reduce the risk of an organ being damaged in the hours and days following a transplant, by maintaining the quality of the donor organ prior to transplantation. Currently, organs cannot survive outside the body for more than around 24 hours. In daily life when an infection or virus meets cells or fluids in the body, it activates a part of the immune system, known as the 'complement' system, which attacks and attempts to destroy the cells of the intruder organism. The complement system is usually kept in check by 'regulators' which are found on the surface of the cells. Their presence prevents it from attacking the body's own cells. However, when an organ is removed for transplantation, complement regulators are lost from the surface of cells due to the lack of blood flow and consequent lack of oxygen. Unregulated, the complement system begins to attack the organ's own cells, severely damaging it. Once the transplant is complete, the effect can be amplified as the complement system supports the recipient's own blood cells in its attack on the organ -- resulting in organ rejection. Working with the biotechnology industry, scientists at the MRC Centre for Transplantation have evolved a method for coating the inner surface of donor kidneys with a protective layer made from a substance which is a natural regulator of these proteins in humans.

Characterization Techniques For Protein Therapeutics - Orthogonal Vs. Complementary





Research and Markets: Global Protein Therapeutics Market Analysis - 2011

DUBLIN--( BUSINESS WIRE )-- Research and Markets ( http://www.researchandmarkets.com/research/b558ed/global_protein_the ) has announced the addition of the " Global Protein Therapeutics Market Analysis " report to their offering.

Within the global pharmaceutical industry, protein therapeutics has been enjoying the fastest growth for the past few years. Playing a significant role in the treatment of many major diseases, protein therapies have revolutionized the methodology followed by drugs. These therapies owe their high efficiency to their targeted approach, which avoids side effects on healthy organs to a great extent. The acceptance of the various protein therapies can be attributed to the increasing prevalence of chronic diseases, such as cancer, diabetes, cardiovascular diseases, and rising penetration of medical insurance.

According to this new research report Global Protein Therapeutics Market Analysis , the global protein therapeutics market is expected to grow at a CAGR of around 13% during 2012-2014. Various factors, such as introduction of new protein therapeutics and enhanced investments will contribute to the buoyant growth of this industry. Besides, augmentation in the number of clinical trials will surface the optimistic performance of the industry.

What do you understand by Bioinformatics of Plant Therapeutics?

The aim of the The above project is to find out which antisense protein interact with gamma gliadin to prevent Celiac disease?
If you were me how would you approach such a topic?


Well for one thing I'd start of by looking at the research papers and all the information available from one of the world's formost institutes see link.



Leave a Reply